BackMedeon Biodesign Overview

Medeon Biodesign Receivables

Medeon Biodesign's receivables is $54M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$53.85M
↓ 16.18% YoYΔ $-10.39M vs prior year quarter

Peer trimmed avg / median

Loading

Medeon Biodesign Receivables History

Loading

Medeon Biodesign vs. peers: Receivables Comparison

Loading

Medeon Biodesign Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Medeon Biodesign (6499.TWO) FAQ

Medeon Biodesign (6499.TWO) currently reports a receivables of $54M as of June 2026. That compares with $64M in the prior-year period — down 16.2% year over year. Use the charts on this page to explore Medeon Biodesign's receivables history and peer comparisons.

Medeon Biodesign's receivables decreased from $64M to $54M — a 16.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medeon Biodesign reported $54M in receivables as of June 2026. That compares with $64M in the prior-year period — down 16.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $54M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medeon Biodesign, and consider following 6499.TWO for alerts when major investors trade the stock.